Select Page

Our Posts

Read our most recent articles and announcements

Eversea Confirms Launch of the World’s First Organic Omega-3 DHA Supplement Across USA

Feb 1, 2021 | Press Releases

Vancouver, B.C., February 01, 2021 – SOLARVEST BIOENERGY INC. (TSXV:SVS) (“Solarvest” or the “Company”), is pleased to provide an update to the December 21, 2020 press release of its highly-bioavailable Organic Omega-3 Children’s Supplement. The product, marketed under the Company’s Eversea brand, is the world’s first and only Organic Omega-3 children’s fruit drop. Eversea seeks to benefit from the extensive and growing market demand for organic, vegetarian and vegan diets. Eversea’s organically certified supplement holds a competitive advantage with several differentiating factors focused on sustainability, environmental conservation, bioavailability and purity, establishing a new market segment for Organic Omega-3 nutraceuticals.

The Eversea Organic Omega-3 Fruit Drop is now available to health conscientious customers throughout the USA directly from its e-commerce web site at Eversea’s webiste and through Amazon listing. This initial Children’s Omega-3 supplement, being Non-GMO, USDA Organic and EU Organic Certified is a unique and a premium entry product that is positioned to take advantage of the significant and growing demand for plant-based products. Eversea’s Organic Omega-3 is over 80% dried fruit, contains no added sugar, tests free from all common allergens and contains the Company’s patented and highly bioavailable Organic Omega-3 DHA powder.

“This Organic Omega-3 Children’s Fruit Drop will appeal to customers looking for a sustainably sourced and organic product, without any nutrient-degrading industrial processing or chemicals. This process yields a pure, whole food Omega-3 with higher bioavailability than flaxseed or hemp which only contain ALA Omega-3. Parents can see a clean ingredient label and feel good about feeding their children a wholesome and healthy supplement,” said Gerri Greenham, President and CEO of Solarvest. He continued,” Our Omega-3 is truly sustainable and produced using organic strains of algae. Eversea specifically set out to reduce the pressure on marine species for harvesting Omega-3 and beneficially this process also ensures that our Organic ingredient is free from any contaminants which may be present in our oceans today.”

The Company further reports that a second product run with its German-based organically certified manufacturer has now successfully concluded. Beyond the Company’s intent to supplement inventory levels, this second Organic DHA ingredient batch will be offered to interested parties both inside and outside North America who have already shown interest in the Organic Omega-3 products. In addition to Company-driven product alternatives, Eversea is engaged to advance the development of a second adolescent offering to complement its Natural Fruit Drop. This product is anticipated to provide organic oriented retailers with house branded products using Eversea’s Omega-3 DHA active ingredient to provide a patented competitive advantage.

The Company is reaching out to larger established distributors to secure a distribution pipeline for its Organic Omega-3 products under the Company’s “Eversea Brand” or other “Home Brands” to achieve scalability and allow the Company to readily market their Organic Omega-3 products.

Corporate

The company also announces that Greg Drohan (see press release dated January 5, 2021) has officially joined the Board of Directors and that Ken Cawkell has resigned from the Board of Directors after many years of valuable service. We thank him for his invaluable contributions and continued support as he will remain on as the corporate lawyer for the Company.

About Solarvest

Solarvest BioEnergy Inc. is an algae biologics company whose production platform provides it with an extremely flexible system capable of producing numerous products from Omega 3 fatty acids to human therapeutic proteins. The company has successfully demonstrated the expression of BMP, a high value therapeutic protein, viral antigens (immune stimulating proteins), and Cecropins (antimicrobial peptide/protein). The company has initiated a program for the expression of CBD and THC to be produced in GMP fermentation facilities.

For further information contact:

Email: invest@solarvest.ca

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Statements made in this news release may contain forward-looking statements that may involve a number of risks and uncertainties. Actual events or results could differ materially from the Company’s expectations and projections.